Allulose vs Sucralose: The 800-Fold Dose Difference That Explains Everything<\/title>\n<\/head>\n<body>\n\n<div class=\"bd-post\">\n<style>\n@import url('https:\/\/fonts.googleapis.com\/css2?family=Inter:wght@500;600;700&display=swap');\n\n.bd-post {\n --prose-width: 744px;\n --gap-attach: 16px;\n --gap-normal: 32px;\n --gap-section: 48px;\n --pad-compact: 16px;\n --pad-standard: 24px;\n --body-bg: #FFFFFF;\n --text-primary: #000000;\n --text-secondary: #666666;\n --text-accent: #3D7A28;\n --card-fill: #F6FCEA;\n --card-border: #5C9647;\n --inverse-bg: #232E34;\n --inverse-text-primary: #FFFFFF;\n --inverse-text-secondary: #A0B0A0;\n --inverse-text-accent: #9FE125;\n --accent: #9FE125;\n --accent-hover: #65A54E;\n --btn-white: #FFFFFF;\n --btn-ink: #232E34;\n font-family: \"Inter\", sans-serif;\n font-size: 16px;\n font-weight: 500;\n line-height: 1.5;\n color: var(--text-primary);\n background: var(--body-bg);\n padding: 40px;\n max-width: 100%;\n box-sizing: border-box;\n}\n.bd-post a { overflow-wrap: anywhere; word-break: break-word; }\n.bd-post p a, .bd-post li a, .bd-post blockquote a, .bd-post td a {\n color: var(--text-accent);\n text-decoration: underline;\n text-decoration-color: var(--card-border);\n text-underline-offset: 2px;\n}\n.bd-post p, .bd-post li { overflow-wrap: break-word; }\n.bd-post .bd-post-article { max-width: var(--prose-width); margin: 0 auto; }\n\n.bd-post p { margin: 0 0 1em; }\n.bd-post h1 { font-family: \"Inter\", sans-serif; font-weight: 600; font-size: 50px; line-height: 1.2; color: var(--text-primary); margin: 0 0 16px; }\n.bd-post h2 { font-family: \"Inter\", sans-serif; font-weight: 600; font-size: 45px; line-height: 1.2; color: var(--text-primary); margin: 48px 0 16px; transform-origin: left center; }\n.bd-post h3 { font-family: \"Inter\", sans-serif; font-weight: 600; font-size: 28px; line-height: 1.2; color: var(--text-primary); margin: 32px 0 12px; }\n.bd-post h4 { font-weight: 600; line-height: 1.2; margin: 24px 0 8px; }\n.bd-post ul, .bd-post ol { margin: 0 0 1em; padding-left: 1.5em; }\n.bd-post li { margin-bottom: 0.5em; }\n.bd-post strong { font-weight: 700; }\n.bd-post em { font-style: italic; }\n\n.bd-post [class*=\"bp-\"] { box-sizing: border-box; }\n.bd-post .bd-post-article > .bp-answer-callout { margin: var(--gap-normal) 0; }\n.bd-post .bd-post-article > .rich-block { margin: var(--gap-normal) 0; }\n.bd-post .bd-post-article > .bp-hook-stat { margin: var(--gap-attach) 0 var(--gap-normal); }\n.bd-post .bd-post-article > .bp-gras-callout { margin: var(--gap-attach) 0 var(--gap-normal); }\n.bd-post .bd-post-article > .bp-cta-mid { margin: var(--gap-section) 0; }\n.bd-post .bd-post-article > .bp-cta-end { margin: var(--gap-section) 0; }\n.bd-post .bd-post-article > .bp-answer-callout:first-child { margin-top: 0; }\n\n\/* BP-0 answer callout (low: tint + border + left bar) *\/\n.bd-post .bp-answer-callout {\n background: var(--card-fill);\n border: 1px solid var(--card-border);\n border-left: 4px solid var(--card-border);\n border-radius: 20px 0 20px 0;\n padding: var(--pad-compact);\n}\n.bd-post .bp-answer-label {\n display: flex; align-items: center; gap: 8px;\n font-size: 18px; font-weight: 600; color: var(--text-accent);\n margin: 0 0 8px;\n}\n.bd-post .bp-answer-icon { display: inline-flex; vertical-align: -0.2em; color: var(--text-accent); }\n.bd-post .bp-answer-text { margin: 0; font-size: 16px; color: var(--text-primary); }\n\n\/* BP-1 hook stat (high: accent solid fill) *\/\n.bd-post .bp-hook-stat {\n background: var(--accent);\n color: var(--btn-ink);\n border-radius: 20px 0 20px 0;\n box-shadow: 5px 5px 0 var(--inverse-bg);\n padding: var(--pad-standard);\n}\n.bd-post .bp-hook-label {\n display: flex; align-items: center; gap: 8px;\n font-size: 16px; font-weight: 600; margin: 0 0 8px;\n}\n.bd-post .bp-hook-icon { display: inline-flex; vertical-align: -0.2em; }\n.bd-post .bp-hook-num { font-size: 64px; font-weight: 700; line-height: 1.1; margin: 0 0 8px; }\n.bd-post .bp-hook-line { font-size: 18px; font-weight: 600; margin: 0 0 8px; }\n.bd-post .bp-hook-micro { font-size: 14px; margin: 0; }\n\n\/* BP-cta-mid (panel-button on card-fill) *\/\n.bd-post .bp-cta-mid {\n background: var(--card-fill);\n border: 1px solid var(--card-border);\n border-radius: 20px 0 20px 0;\n padding: var(--pad-standard);\n display: flex; align-items: center; justify-content: space-between; gap: 24px;\n}\n.bd-post .bp-cta-mid-text { margin: 0; font-size: 17px; color: var(--text-primary); }\n.bd-post .bp-cta-mid-btn {\n display: inline-flex; align-items: center; gap: 8px;\n background: var(--btn-ink); color: var(--btn-white);\n border-radius: 100px; padding: 15px 28px;\n font-size: 16px; font-weight: 600; line-height: 1.2;\n text-decoration: none; white-space: nowrap;\n transition: transform .2s ease-out, box-shadow .2s ease-out;\n}\n\n\/* BP-3 GRAS callout (low) *\/\n.bd-post .bp-gras-callout {\n background: var(--card-fill);\n border: 1px solid var(--card-border);\n border-left: 4px solid var(--card-border);\n border-radius: 20px 0 20px 0;\n padding: var(--pad-compact);\n}\n.bd-post .bp-gras-label {\n display: flex; align-items: center; gap: 8px;\n font-size: 18px; font-weight: 600; color: var(--text-accent);\n margin: 0 0 8px;\n}\n.bd-post .bp-gras-icon { display: inline-flex; vertical-align: -0.2em; color: var(--text-accent); }\n.bd-post .bp-gras-text { margin: 0; font-size: 16px; color: var(--text-primary); }\n\n\/* BP-cta-end (panel-button on inverse) *\/\n.bd-post .bp-cta-end {\n background: var(--inverse-bg);\n border-radius: 20px 0 20px 0;\n padding: 32px 40px;\n display: flex;\n flex-direction: column;\n align-items: center;\n text-align: center;\n}\n.bd-post .bp-cta-end-head { display: flex; align-items: center; justify-content: center; gap: 12px; }\n.bd-post .bp-cta-end-icon { display: flex; flex: 0 0 auto; margin: 0; color: var(--inverse-text-accent); }\n.bd-post .bp-cta-end-title { font-size: 24px; font-weight: 600; color: var(--inverse-text-primary); margin: 0; }\n.bd-post .bp-cta-end-sub { max-width: 680px; font-size: 16px; line-height: 1.45; color: var(--inverse-text-secondary); margin: 12px 0 20px; }\n.bd-post .bp-cta-end-btn {\n display: inline-flex; align-items: center; gap: 8px;\n background: var(--accent); color: var(--btn-ink);\n border-radius: 100px; padding: 15px 28px;\n font-size: 16px; font-weight: 600; line-height: 1.2;\n text-decoration: none; white-space: nowrap;\n transition: transform .2s ease-out, box-shadow .2s ease-out;\n}\n\n\/* References *\/\n.bd-post .bd-refs { margin: var(--gap-section) 0 0; border-top: 1px solid var(--card-border); }\n.bd-post .bd-refs h2 { font-size: 28px; margin: 48px 0 16px; }\n.bd-post .bd-refs ol { margin: 0; padding-left: 1.5em; }\n.bd-post .bd-refs li { font-size: 14px; line-height: 1.5; color: var(--text-secondary); overflow-wrap: anywhere; word-break: break-word; }\n\n\/* Rich elements *\/\n.bd-post .rich-block {\n background: var(--card-fill);\n border: 1px solid var(--card-border);\n border-radius: 20px 0 20px 0;\n padding: var(--pad-standard);\n}\n.bd-post .rich-title { font-size: 20px; font-weight: 600; color: var(--text-primary); margin: 0 0 12px; }\n.bd-post .rich-title-icon { display: inline-flex; vertical-align: -0.2em; margin-right: 8px; color: var(--text-accent); }\n.bd-post .rich-source { font-size: 13px; color: var(--text-secondary); margin: 12px 0 0; }\n.bd-post .table-wrapper { overflow-x: auto; }\n.bd-post .rich-table table { width: 100%; border-collapse: collapse; font-size: 14px; }\n.bd-post .rich-table th {\n background: var(--card-fill); text-align: left;\n font-weight: 600; color: var(--text-primary);\n border-bottom: 2px solid var(--card-border);\n padding: 10px 12px;\n}\n.bd-post .rich-table td {\n color: var(--text-primary);\n border-bottom: 1px solid var(--card-border);\n padding: 10px 12px; vertical-align: top;\n}\n.bd-post .rich-table tr:last-child td { border-bottom: none; }\n.bd-post .rich-stats-grid { display: grid; grid-template-columns: repeat(2, 1fr); gap: 16px; }\n.bd-post .rich-stat-num { font-size: 28px; font-weight: 700; color: var(--text-accent); margin: 0 0 4px; }\n.bd-post .rich-stat-label { font-size: 14px; color: var(--text-secondary); margin: 0; }\n.bd-post .rich-checklist { display: flex; flex-direction: column; gap: 12px; }\n.bd-post .rich-check-item { display: flex; align-items: flex-start; gap: 8px; margin: 0; }\n.bd-post .rich-check-item svg { flex: 0 0 auto; color: var(--text-accent); margin-top: 3px; }\n.bd-post .rich-check-item span { font-size: 15px; color: var(--text-primary); }\n\n\/* Sanctioned motion *\/\n@media (prefers-reduced-motion: no-preference) {\n @supports (animation-timeline: view()) {\n .bd-post .bd-reveal { animation: bd-fade-in linear both; animation-timeline: view(); animation-range: entry 0% entry 35%; }\n @keyframes bd-fade-in { from { opacity: 0; } to { opacity: 1; } }\n }\n .bd-post h2 { transition: color 0.2s ease-out, transform 0.2s ease-out; }\n .bd-post h2:hover { color: var(--text-accent); transform: scale(1.01); }\n .bd-post .bp-hook-stat { transition: transform .2s ease-out, box-shadow .2s ease-out; }\n .bd-post .bp-hook-stat:hover { transform: translateY(-2px); box-shadow: 7px 7px 0 var(--inverse-bg); }\n .bd-post .bp-cta-mid-btn:hover {\n background: var(--accent-hover); color: var(--btn-ink);\n transform: translateY(-2px); box-shadow: 0 6px 18px rgba(0,0,0,0.15);\n }\n .bd-post .bp-cta-end-btn:hover {\n background: var(--btn-white); color: var(--btn-ink);\n transform: translateY(-2px); box-shadow: 0 6px 18px rgba(0,0,0,0.25);\n }\n .bd-post .bd-post-article a { transition: color .2s ease-out, text-decoration-color .2s ease-out; }\n}\n\n@media (max-width: 768px) {\n .bd-post { padding: 16px; }\n .bd-post h1 { font-size: 32px; }\n .bd-post h2 { font-size: 30px; margin-top: 32px; }\n .bd-post h3 { font-size: 20px; margin-top: 24px; }\n .bd-post .bd-refs h2 { font-size: 22px; }\n .bd-post .bp-hook-num { font-size: 48px; }\n .bd-post .bp-hook-line { font-size: 16px; }\n .bd-post .bp-cta-mid { flex-direction: column; align-items: flex-start; }\n .bd-post .bp-cta-mid-btn, .bd-post .bp-cta-end-btn { display: flex; width: 100%; justify-content: center; }\n .bd-post .rich-stats-grid { grid-template-columns: 1fr; }\n .bd-post .bp-cta-end-title { font-size: 20px; }\n .bd-post .bp-cta-end { align-items: center; padding: 24px; text-align: center; }\n .bd-post .bp-cta-end-head { gap: 10px; align-items: flex-start; }\n .bd-post .bp-answer-label, .bd-post .bp-gras-label { font-size: 16px; }\n}\n\/* Force the bottom border of every rich table *\/\n.bd-post .rich-table {\n border-bottom: 1px solid var(--card-border) !important;\n}\n\n.bd-post .rich-table tbody tr:last-child > th,\n.bd-post .rich-table tbody tr:last-child > td,\n.bd-post .rich-table > tr:last-child > th,\n.bd-post .rich-table > tr:last-child > td {\n border-bottom: 1px solid var(--card-border) !important;\n}\n<\/style>\n<article class=\"bd-post-article\">\n\n\n<div class=\"bp-answer-callout bd-reveal\">\n <p class=\"bp-answer-label\"><span class=\"bp-answer-icon\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"18\" height=\"18\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><circle cx=\"12\" cy=\"12\" r=\"10\"\/><path d=\"M12 16v-4\"\/><path d=\"M12 8h.01\"\/><\/svg><\/span>The short answer<\/p>\n <p class=\"bp-answer-text\">No. They are not the same thing, and not even the same kind of sweetener.<\/p>\n<\/div>\n\n<h2>Two Sweeteners, Two Categories: What Allulose and Sucralose Actually Are<\/h2>\n<p>Allulose is a rare sugar: a C-3 epimer of fructose that occurs naturally in trace amounts in figs, raisins, wheat, and maple syrup, and is produced commercially from starch-derived fructose (<a href=\"https:\/\/health.clevelandclinic.org\/what-is-allulose\">Cleveland Clinic<\/a>, 2024). Sucralose is a chlorinated derivative of table sugar, roughly 600 times sweeter, regulated in the United States as a food additive (<a href=\"https:\/\/www.fda.gov\/food\/food-additives-petitions\/aspartame-and-other-sweeteners-food\">FDA<\/a>, 2025).<\/p>\n<p>The difference that organizes everything else is the category each one works in. Allulose is a <strong>bulk sweetener<\/strong>: you dose it by weight, close to sugar, and it brings physical mass into a recipe. Sucralose is a <strong>high-intensity sweetener<\/strong>: you dose it in parts per million, and it brings sweetness and nothing else. In typical use, allulose enters at 125 to 140 percent of sugar’s weight to match its sweetness. Sucralose enters at around 0.16 percent (<a href=\"https:\/\/bevi.co\/blog\/allulose-sugar\/\">Bevi<\/a>, 2025). That works out to a dose gap of roughly 800 times between the two.<\/p>\n<p>Part of the confusion online comes from a naming fight that regulators never joined. Some medical content calls allulose an “artificial sweetener” while describing it, in the same article, as a naturally occurring sugar; brand blogs insist allulose is natural and sucralose is artificial. The regulatory categories are different from both. FDA recognizes allulose as a low-calorie sweetener with GRAS status and treats sucralose as a food additive with an acceptable daily intake (<a href=\"https:\/\/www.fda.gov\/food\/food-additives-petitions\/aspartame-and-other-sweeteners-food\">FDA<\/a>, 2025). “Natural versus artificial” is a marketing binary, not a regulatory one, and it explains why the search results disagree with each other more than with the underlying facts.<\/p>\n<p>One more source of confusion is worth clearing up immediately, because it generates a huge share of the “are they the same” searches: the best-known sucralose tabletop brand also sells a line of allulose products under the same brand name. The brand’s own FAQ states that its yellow packets are sucralose and that its allulose products contain no sucralose (Splenda FAQ, 2026). Same brand, two unrelated sweeteners. If you have seen both names near each other on a shelf, that is why.<\/p>\n\n<div class=\"rich-block rich-table bd-reveal\">\n <p class=\"rich-title\">Allulose and Sucralose: The Foundation Comparison<\/p>\n <div class=\"table-wrapper\">\n <table>\n <thead><tr><th>Dimension<\/th><th>Allulose<\/th><th>Sucralose<\/th><\/tr><\/thead>\n <tbody>\n <tr><td>Origin & chemistry<\/td><td>Rare sugar, C-3 epimer of fructose, produced from starch-derived fructose<\/td><td>Chlorinated derivative of sucrose (E955)<\/td><\/tr>\n <tr><td>Sweetness vs sugar<\/td><td>About 70%<\/td><td>About 600x<\/td><\/tr>\n <tr><td>Typical use level<\/td><td>125–140% of sugar’s weight<\/td><td>~0.16% of sugar’s weight<\/td><\/tr>\n <tr><td>Calories<\/td><td>0.4 kcal\/g<\/td><td>0 per molecule (packet carriers add ~3 kcal\/serving)<\/td><\/tr>\n <tr><td>US status<\/td><td>Low-calorie sweetener, GRAS<\/td><td>Food additive, ADI 5 mg\/kg bw\/day<\/td><\/tr>\n <tr><td>What it brings to a formula<\/td><td>Sweetness + bulk + browning<\/td><td>Sweetness only<\/td><\/tr>\n <\/tbody>\n <\/table>\n <\/div>\n <p class=\"rich-source\">DataSource: FDA (2025, 2020); Bevi (2025); UC Davis; published manufacturer spec sheets<\/p>\n<\/div>\n\n<p>With the categories separated, the practical question changes shape. It is no longer “which one is better,” but “what does an equal-sweetness swap actually deliver,” which is a very different calculation than most articles give you.<\/p>\n\n<h2>What an Equal-Sweetness Swap Actually Delivers: Dose, Calories, and Tolerance<\/h2>\n<h3>The 800-Fold Usage Gap<\/h3>\n<p>To replace the sweetness of one gram of sugar, you need about 1.3 grams of allulose. To replace it with sucralose, you need about 0.0016 grams (<a href=\"https:\/\/bevi.co\/blog\/allulose-sugar\/\">Bevi<\/a>, 2025).<\/p>\n\n\n<div class=\"bp-hook-stat bd-reveal\">\n <p class=\"bp-hook-label\"><span class=\"bp-hook-icon\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"20\" height=\"20\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><polyline points=\"22 7 13.5 15.5 8.5 10.5 2 17\"\/><polyline points=\"16 7 22 7 22 13\"\/><\/svg><\/span>The dose gap<\/p>\n <p class=\"bp-hook-num\">800×<\/p>\n <p class=\"bp-hook-line\">Swap for sweetness and you shift the dose by roughly 800-fold. Every downstream difference in this article follows from that one number.<\/p>\n <p class=\"bp-hook-micro\">Equal sweetness: 1.3× the weight in allulose vs 0.16% in sucralose<\/p>\n<\/div>\n\n<p>Calorie math, digestive tolerance, baking behavior, even the shape of the safety studies: all of it is the 800-fold gap, wearing different costumes.<\/p>\n<h3>What a Serving Actually Delivers<\/h3>\n<p>Allulose contributes 0.4 kcal\/g. Under FDA’s final labeling guidance, manufacturers count it in calories at 0.4 kcal\/g but may exclude it from the Total Sugars and Added Sugars declarations (<a href=\"https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/guidance-industry-declaration-allulose-and-calories-allulose-nutrition-and-supplement-facts-labels\">FDA<\/a>, 2020). Because you use it at sugar-like weights, the calories are small but real: a cup of one popular keto cereal carries about 10 g of allulose (<a href=\"https:\/\/www.cspi.org\/article\/which-low-calorie-sweeteners-are-safe-and-which-arent\">CSPI<\/a>, 2023).<\/p>\n<p>Sucralose is the opposite case. The molecule delivers zero calories, but granulated packet products get their bulk from dextrose and maltodextrin carriers, and one packet delivers about 3 kcal while sweetening like two teaspoons of sugar (<a href=\"https:\/\/nutrition.ucdavis.edu\/outreach\/nutr-health-info-sheets\/pro-nonnutritive-sweeteners\">UC Davis<\/a>; <a href=\"https:\/\/www.fda.gov\/media\/168517\/download?attachment\">FDA<\/a>). If you count net carbs, the “zero calorie” packet is not zero-carb, which is exactly why low-carb bakers migrate to liquid sucralose drops, which skip the carrier entirely. Neither sweetener’s label story survives at the serving level without reading the other ingredients.<\/p>\n<h3>Tolerance Runs on Two Different Systems<\/h3>\n<p>Allulose tolerance is <strong>threshold-based<\/strong>: fine at moderate doses, dose-dependent at high ones. In a 29-person escalating-dose study, participants had no symptoms at a single 27 g dose, while roughly one third reported diarrhea, bloating, or abdominal pain at about 35 g (figures scaled to a 150-pound adult) (<a href=\"https:\/\/www.cspi.org\/article\/which-low-calorie-sweeteners-are-safe-and-which-arent\">CSPI<\/a>, 2023). China’s approval sets a recommended intake of no more than 20 g\/day and excludes infants, pregnant and breastfeeding women (<a href=\"https:\/\/zwfw.nhc.gov.cn\/kzx\/tzgg\/sptjjxpzsp_224\/202507\/t20250702_3106.html\">NHC Announcement No. 4, 2025<\/a>, 2025). Individual sensitivity varies; some people report digestive effects well below the trial thresholds.<\/p>\n<p>Sucralose tolerance is <strong>ADI-based<\/strong>: 5 mg per kilogram of body weight per day (<a href=\"https:\/\/www.fda.gov\/food\/food-additives-petitions\/aspartame-and-other-sweeteners-food\">FDA<\/a>, 2025). For a 60 kg adult, that is about 300 mg\/day, orders of magnitude above typical dietary exposure from finished products. The two systems are not comparable: a dose-based threshold and a body-weight ADI answer different questions, and treating them as equivalent is a category error.<\/p>\n\n<div class=\"rich-block rich-stats bd-reveal\">\n <p class=\"rich-title\"><span class=\"rich-title-icon\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"20\" height=\"20\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><polyline points=\"22 7 13.5 15.5 8.5 10.5 2 17\"\/><polyline points=\"16 7 22 7 22 13\"\/><\/svg><\/span>The Threshold Numbers<\/p>\n <div class=\"rich-stats-grid\">\n <div><p class=\"rich-stat-num\">27 g<\/p><p class=\"rich-stat-label\">Allulose single dose — no symptoms (29-person trial, 150-lb basis)<\/p><\/div>\n <div><p class=\"rich-stat-num\">~35 g<\/p><p class=\"rich-stat-label\">About 1\/3 of adults report GI effects at this single dose<\/p><\/div>\n <div><p class=\"rich-stat-num\">≤ 20 g\/day<\/p><p class=\"rich-stat-label\">Allulose recommended intake (China NHC approval)<\/p><\/div>\n <div><p class=\"rich-stat-num\">5 mg\/kg<\/p><p class=\"rich-stat-label\">Sucralose ADI, per kg body weight per day (≈300 mg for a 60 kg adult)<\/p><\/div>\n <\/div>\n <p class=\"rich-source\">DataSource: CSPI (2023); NHC Announcement No. 4 (2025); FDA (2025)<\/p>\n<\/div>\n\n<h3>The Kidney Question, Answered Precisely<\/h3>\n<p>A recurring search asks whether allulose is hard on the kidneys. The precise answer: allulose is absorbed in the small intestine, not metabolized, and excreted by the kidneys mostly intact (<a href=\"https:\/\/health.clevelandclinic.org\/what-is-allulose\">Cleveland Clinic<\/a>, 2024). Renal excretion is a <em>route<\/em>, not an injury. No published evidence shows kidney damage at recommended intakes, and the honest position is that long-term high-dose data are still accumulating. “It passes through the kidneys” and “it burdens the kidneys” are different claims; only the first is supported.<\/p>\n<p>That is what crosses the consumer’s plate. What happens inside a formulation follows the same 800-fold logic, and it is where the two sweeteners stop competing altogether.<\/p>\n\n\n<div class=\"bp-cta-mid bd-reveal\">\n <p class=\"bp-cta-mid-text\">Need these thresholds as a working document? We publish the complete allulose crystal and syrup spec tables.<\/p>\n <a class=\"bp-cta-mid-btn\" href=\"https:\/\/www.saigaoingredients.com\/contact\/\">Request the spec sheet<svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"18\" height=\"18\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><path d=\"M5 12h14\"\/><path d=\"m12 5 7 7-7 7\"\/><\/svg><\/a>\n<\/div>\n\n<h2>Inside the Formula: Why Real Products Use Both Together<\/h2>\n<p>A bulk sweetener does structural work. Allulose, as a reducing sugar, participates in the Maillard reaction: it browns like sucrose, often faster (<a href=\"https:\/\/bevi.co\/blog\/allulose-sugar\/\">Bevi<\/a>, 2025). It retains moisture in baked goods, depresses freezing point for scoopable ice cream, and does not crystallize into grit the way erythritol can. A high-intensity sweetener does none of this. Sucralose provides sweetness at negligible mass; it cannot build crust color, body, or bulk, because it contributes essentially no mass at all.<\/p>\n<p>This is why real products so often contain both. A reader on a nutrition forum put it plainly while reviewing a keto product’s label: “Allulose is only about 70 percent as sweet as table sugar. So the sucralose makes up for that deficiency.” A 70-percent-sweet bulk sugar plus a 600-times-sweet intensity top-up cover each other’s gaps: the bulk side brings mass, browning, and sugar-like taste; the intensity side closes the sweetness deficit without adding weight or cost. The market has already voted on this structure: the biggest sucralose tabletop brand now sells an allulose-based baking line under its own roof (Splenda FAQ, 2026). “Allulose vs sucralose” is, in formulation terms, mostly a false binary. They are colleagues, not candidates.<\/p>\n\n<div class=\"rich-block rich-table bd-reveal\">\n <p class=\"rich-title\">Who Brings What into the Formula<\/p>\n <div class=\"table-wrapper\">\n <table>\n <thead><tr><th>Function<\/th><th>Allulose (bulk)<\/th><th>Sucralose (high-intensity)<\/th><\/tr><\/thead>\n <tbody>\n <tr><td>Sweetness<\/td><td>70% of sugar; sugar-like, no aftertaste<\/td><td>600x; tops up any gap at ppm dose<\/td><\/tr>\n <tr><td>Bulk & structure<\/td><td>Full mass contribution; body and texture<\/td><td>None; negligible mass<\/td><\/tr>\n <tr><td>Browning & crust<\/td><td>Reducing sugar; browns via Maillard, often faster than sugar<\/td><td>No browning contribution<\/td><\/tr>\n <tr><td>Moisture<\/td><td>Retains moisture in soft textures<\/td><td>No moisture function<\/td><\/tr>\n <tr><td>Frozen texture<\/td><td>Depresses freezing point; smooth, scoopable<\/td><td>No freezing-point function<\/td><\/tr>\n <tr><td>Cost-in-use<\/td><td>Priced per kg, used at 1.3x sugar weight<\/td><td>Tiny dose; lowest cost per sweetness unit<\/td><\/tr>\n <\/tbody>\n <\/table>\n <\/div>\n <p class=\"rich-source\">DataSource: Bevi (2025); published allulose crystal & syrup spec sheets; CSPI (2023)<\/p>\n<\/div>\n\n<p>The swap rules follow directly. Replacing sugar with allulose: use about 1.3 times the weight, expect faster browning, and adjust by lowering oven temperature roughly 25°F or shortening bake time while watching crust color. Replacing sugar with sucralose by weight is where recipes break predictably: crust color, caramel notes, cookie spread, and bulk all come from sugar’s mass and reducing activity, none of which a ppm-dose sweetener supplies. The boundary is easy to state as a check: if the recipe’s color and structure come from sugar, only a bulk sweetener can carry them; if only sweetness matters (beverages, sauces, tabletop use), the high-intensity option wins on cost-in-use. And one moisture caveat cuts the other way: allulose holds water, so shelf-life and water activity calculations should be redone when it enters a formula at sugar-like levels.<\/p>\n<p>Formulation behavior, however, is only half of the professional’s checklist. The other half is evidence and market access, where the two sweeteners are treated very differently by regulators and retailers alike.<\/p>\n\n<h2>What the Evidence Says, and Where Each Sweetener Can Be Sold<\/h2>\n<h3>Why the Safety Verdicts Disagree<\/h3>\n<p>The public record looks contradictory because the two sweeteners generate two different shapes of evidence. A bulk sweetener eaten at gram-level dietary exposure gets tested with dose-response and tolerance trials. A high-intensity sweetener consumed at milligram levels gets tested with ADI toxicology and mechanism studies. Comparing them on one scale produces exactly the confusion you see in the search results.<\/p>\n<p>Take the two most quoted verdicts. A consumer-advocacy review concludes: “Allulose is safe, but it may cause GI woes in sensitive people,” while flagging that no studies have tested allulose in children or people with GI conditions (<a href=\"https:\/\/www.cspi.org\/article\/which-low-calorie-sweeteners-are-safe-and-which-arent\">CSPI<\/a>, 2023). A cardiovascular researcher known for erythritol and xylitol clotting studies recommends avoiding allulose until more data exist (<a href=\"https:\/\/health.clevelandclinic.org\/what-is-allulose\">Cleveland Clinic<\/a>, 2024). He states plainly that allulose-specific studies are not available, and that his caution is extrapolated from other sweeteners. Those are not contradictory facts; they are different evidence standards applied to the same thin long-term record.<\/p>\n<p>Sucralose’s evidence file has its own texture. An animal study reported leukemia in mice exposed from fetus to death, summarized by the same consumer review with the caveat that results across studies are mixed (<a href=\"https:\/\/www.cspi.org\/article\/which-low-calorie-sweeteners-are-safe-and-which-arent\">CSPI<\/a>, 2023). In the best human trial on record, 60 adults consumed the equivalent of about six packets a day for two weeks and showed reduced glucose tolerance; stool transplants from the top responders transmitted the effect to germ-free mice, implicating microbiome changes (<a href=\"https:\/\/www.cspi.org\/article\/which-low-calorie-sweeteners-are-safe-and-which-arent\">CSPI<\/a>, 2023). None of these findings is dispositive on its own. Each answers a different question, and a formulation decision should know which question it is asking.<\/p>\n\n <img decoding=\"async\" src=\"https:\/\/www.saigaoingredients.com\/wp-content\/uploads\/2026\/09\/Allulose-vs-Sucralose.webp\" style=\"width: 512px; height: 384px; max-width: 100%; object-fit: cover; border-radius: 12px; margin: 30px auto; display: block; box-shadow: 10px 10px 60px 0px rgba(210, 221, 224, 0.35); transition: all 0.3s ease; cursor: pointer;\" onmouseover=\"this.style.transform='translateY(-5px) scale(1.03)'; this.style.boxShadow='15px 25px 80px 0px rgba(210, 221, 224, 0.45)'\" onmouseout=\"this.style.transform='translateY(0) scale(1)'; this.style.boxShadow='10px 10px 60px 0px rgba(210, 221, 224, 0.35)'\"> \n\n<h3>The Head-to-Head Data That Exists So Far<\/h3>\n<p>Direct comparisons are rare but they are starting to appear. A 2025 systematic review in <em>Current Developments in Nutrition<\/em> compared allulose against other sweeteners across glycemic and cardiometabolic outcomes: allulose reduced BMI relative to sucralose over 12 weeks, and improved post-prandial glucose relative to aspartame (<a href=\"https:\/\/cdn.nutrition.org\/article\/S2475-2991(25)02060-8\/fulltext\">Hamann et al.<\/a>, 2025). The evidence base is young and the review is comparative, not mechanistic, but the direction matters: the first head-to-head data do not flatter sucralose. Meanwhile, per the consumer review’s summary, sucralose is one of only two sweeteners with consistent microbiome-altering signals in sensitive people.<\/p>\n<h3>Where Each Sweetener Can Be Sold<\/h3>\n<p>Regulatory status is where formulation decisions meet market decisions. The map, as of this writing:<\/p>\n\n<div class=\"rich-block rich-table bd-reveal\">\n <p class=\"rich-title\">Market Access and Labeling: Allulose vs Sucralose<\/p>\n <div class=\"table-wrapper\">\n <table>\n <thead><tr><th>Market<\/th><th>Allulose<\/th><th>Sucralose<\/th><\/tr><\/thead>\n <tbody>\n <tr><td>United States<\/td><td>GRAS; excluded from Total & Added Sugars; calories at 0.4 kcal\/g<\/td><td>Approved food additive; ADI 5 mg\/kg bw\/day<\/td><\/tr>\n <tr><td>European Union<\/td><td>Not approved; novel food applications pending (often mislabeled “banned”)<\/td><td>Approved (E955)<\/td><\/tr>\n <tr><td>Canada<\/td><td>Not approved as a food sweetener<\/td><td>Approved<\/td><\/tr>\n <tr><td>China<\/td><td>Approved July 2025 as novel food ingredient: ≥98 g\/100 g purity, recommended ≤20 g\/day, not for infants\/pregnant\/breastfeeding<\/td><td>Approved food additive<\/td><\/tr>\n <tr><td>Japan, Korea, Mexico, Singapore<\/td><td>Approved early<\/td><td>Approved<\/td><\/tr>\n <\/tbody>\n <\/table>\n <\/div>\n <p class=\"rich-source\">DataSource: FDA (2020, 2025); NHC Announcement No. 4 (2025); Cleveland Clinic (2024); EU\/CA status per cited reviews<\/p>\n<\/div>\n\n<p>Two details on that map deserve attention. First, the energy factor assigned to allulose is not globally uniform: China’s announcement pegs it at ≈1.67 kJ\/g (about 0.4 kcal\/g), and other regulators set their own values, so label math does not transfer across borders unchanged.<\/p>\n<p>Second, “approved” and “available everywhere” are different questions, because retailers run their own standards on top of the regulators’. Whole Foods Market’s ingredient standards ban more than 300 ingredients and explicitly name sucralose, alongside aspartame and saccharin (<a href=\"https:\/\/www.wholefoodsmarket.com\/quality-standards\/food-ingredient-standards\">Whole Foods Market<\/a>, 2026); industry reporting indicates allulose is excluded there as well, though the official page does not name it, so treat that one as reported rather than official (Icon Foods, 2025). The actionable version of this: before locking a sweetener system for a product, verify regulatory status for each target market <em>and<\/em> the ingredient standards of your target retail channels.<\/p>\n\n\n<div class=\"bp-gras-callout bd-reveal\">\n <p class=\"bp-gras-label\"><span class=\"bp-gras-icon\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"18\" height=\"18\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><path d=\"m21.73 18-8-14a2 2 0 0 0-3.48 0l-8 14A2 2 0 0 0 4 20h16a2 2 0 0 0 1.73-2Z\"\/><path d=\"M12 9v4\"\/><path d=\"M12 17h.01\"\/><\/svg><\/span>Channel check<\/p>\n <p class=\"bp-gras-text\">GRAS status is federal approval, not guaranteed shelf access. Before locking a sweetener system, verify each target market’s regulatory status and every target retailer’s ingredient standards: both can exclude an approved sweetener.<\/p>\n<\/div>\n\n<h2>Choosing a Sweetener System: What to Ask a Supplier<\/h2>\n<p>Once the categories are clear, the purchase question stops being “which sweetener is better” and becomes “which one carries the bulk, and which one closes the sweetness gap.” Bakery and frozen applications tend to go allulose-forward, because browning, moisture, and freezing-point depression are the product. Beverage and sauce applications tend to go intensity-forward, because only sweetness matters and cost-per-sweetness dominates. Tabletop blends and keto confectionery increasingly do both at once. The market signal is consistent: commercial beverage operators are publicly evaluating allulose for their lines, and the leading sucralose brand already sells allulose-based baking products (<a href=\"https:\/\/bevi.co\/blog\/allulose-sugar\/\">Bevi<\/a>, 2025; Splenda FAQ, 2026).<\/p>\n<p>Cost comparisons only work in one accounting mode. Per-kilogram price is meaningless across categories when one ingredient goes in at 1.3 times sugar weight and the other at 0.16 percent. Per-sweetness-unit price favors sucralose but ignores everything the bulk side contributes. The only number that survives contact with a real recipe is cost-in-use: the system total, including carriers, bulking corrections, and label consequences. Ask every supplier to quote on that basis, or the quotes are not comparable.<\/p>\n<p>The supplier evaluation is then a short, checkable list:<\/p>\n\n<div class=\"rich-block rich-checklist bd-reveal\">\n <p class=\"rich-title\"><span class=\"rich-title-icon\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"20\" height=\"20\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><path d=\"m3 17 2 2 4-4\"\/><path d=\"m3 7 2 2 4-4\"\/><path d=\"M13 6h8\"\/><path d=\"M13 12h8\"\/><path d=\"M13 18h8\"\/><\/svg><\/span>Supplier Evaluation Checklist<\/p>\n <div class=\"rich-checklist\">\n <p class=\"rich-check-item\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"18\" height=\"18\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><circle cx=\"12\" cy=\"12\" r=\"10\"\/><path d=\"m9 12 2 2 4-4\"\/><\/svg><span>Can one source supply both lines (bulk + high-intensity), plus blends?<\/span><\/p>\n <p class=\"rich-check-item\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"18\" height=\"18\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><circle cx=\"12\" cy=\"12\" r=\"10\"\/><path d=\"m9 12 2 2 4-4\"\/><\/svg><span>Are spec tables published for every form offered?<\/span><\/p>\n <p class=\"rich-check-item\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"18\" height=\"18\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><circle cx=\"12\" cy=\"12\" r=\"10\"\/><path d=\"m9 12 2 2 4-4\"\/><\/svg><span>Is blending and spec customization available (viscosity, purity, pH, water activity, particle form, packaging)?<\/span><\/p>\n <p class=\"rich-check-item\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"18\" height=\"18\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><circle cx=\"12\" cy=\"12\" r=\"10\"\/><path d=\"m9 12 2 2 4-4\"\/><\/svg><span>Will they hand over COA and certification documents directly?<\/span><\/p>\n <p class=\"rich-check-item\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"18\" height=\"18\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><circle cx=\"12\" cy=\"12\" r=\"10\"\/><path d=\"m9 12 2 2 4-4\"\/><\/svg><span>What are realistic lead times and MOQ for your volumes?<\/span><\/p>\n <p class=\"rich-check-item\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"18\" height=\"18\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><circle cx=\"12\" cy=\"12\" r=\"10\"\/><path d=\"m9 12 2 2 4-4\"\/><\/svg><span>What is their response time on technical questions?<\/span><\/p>\n <\/div>\n <p class=\"rich-source\">DataSource: Published supplier terms: SAIGAO allulose line and tailored-solutions pages<\/p>\n<\/div>\n\n<p>We build our own published terms around exactly that checklist. Our <a href=\"https:\/\/www.saigaoingredients.com\/sweeteners\/allulose\/\">allulose line<\/a> covers crystal and syrup with full public spec tables: crystal at ≥98.5% D-allulose on a dry basis, syrup at ≥95.0% content with ≥70.0% dry matter, alongside published pH, ash, and microbiological limits. We supply and blend both sweetener lines, and we adjust eight published customization axes: viscosity, purity\/assay, pH, water activity, form and particle size, DE value, fiber content, and packaging (<a href=\"https:\/\/www.saigaoingredients.com\/tailored-solutions\/\">customization<\/a>). Operationally: in-stock powder ships in 7 days, custom orders run 20 to 30 days, bulk orders start at 1 ton, and international inquiries get a 12-hour response.<\/p>\n<p><em>The “which is better” question dissolves once you ask the formulator’s question instead: who carries the bulk, and who closes the sweetness gap. If you want spec sheets and samples to run your own side-by-side trials, <a href=\"https:\/\/www.saigaoingredients.com\/contact\/\">request them here<\/a>.<\/em><\/p>\n\n\n<div class=\"bp-cta-end bd-reveal\">\n <div class=\"bp-cta-end-head\">\n <p class=\"bp-cta-end-icon\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"28\" height=\"28\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><path d=\"M14.536 21.686a.5.5 0 0 0 .937-.024l6.5-19a.496.496 0 0 0-.635-.635l-19 6.5a.5.5 0 0 0-.024.937l7.93 3.18a2 2 0 0 1 1.112 1.11z\"\/><path d=\"m21.854 2.147-10.94 10.939\"\/><\/svg><\/p>\n <p class=\"bp-cta-end-title\">Test Both Sweeteners in Your Own Formula<\/p>\n <\/div>\n <p class=\"bp-cta-end-sub\">Allulose crystal & syrup spec sheets, COA documents and samples. Bulk from 1 ton, custom blends and 8-axis customization.<\/p>\n <a class=\"bp-cta-end-btn\" href=\"https:\/\/www.saigaoingredients.com\/contact\/\">Get Spec Sheets & Samples<svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"18\" height=\"18\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><path d=\"M5 12h14\"\/><path d=\"m12 5 7 7-7 7\"\/><\/svg><\/a>\n<\/div>\n\n<div class=\"bd-refs\">\n<h2>References<\/h2>\n<ol>\n <li>U.S. Food and Drug Administration. “Guidance for Industry: The Declaration of Allulose and Calories From Allulose on Nutrition and Supplement Facts Labels.” 2020. <a href=\"https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/guidance-industry-declaration-allulose-and-calories-allulose-nutrition-and-supplement-facts-labels\" target=\"_blank\" rel=\"noopener\">fda.gov<\/a><\/li>\n <li>U.S. Food and Drug Administration. “Aspartame and Other Sweeteners in Food.” 2025. <a href=\"https:\/\/www.fda.gov\/food\/food-additives-petitions\/aspartame-and-other-sweeteners-food\" target=\"_blank\" rel=\"noopener\">fda.gov<\/a><\/li>\n <li>U.S. Food and Drug Administration. “Safe Levels of Sweeteners (ADI Reference Table).” <a href=\"https:\/\/www.fda.gov\/media\/168517\/download?attachment\" target=\"_blank\" rel=\"noopener\">fda.gov<\/a><\/li>\n <li>National Health Commission of China. “Announcement on 20 ‘Three-New Foods,’ Including D-Allulose (Announcement No. 4 of 2025).” 2025. <a href=\"https:\/\/zwfw.nhc.gov.cn\/kzx\/tzgg\/sptjjxpzsp_224\/202507\/t20250702_3106.html\" target=\"_blank\" rel=\"noopener\">nhc.gov.cn<\/a><\/li>\n <li>UC Davis Clinical Nutrition. “Nutrition & Health Info Sheets: Nonnutritive Sweeteners.” <a href=\"https:\/\/nutrition.ucdavis.edu\/outreach\/nutr-health-info-sheets\/pro-nonnutritive-sweeteners\" target=\"_blank\" rel=\"noopener\">nutrition.ucdavis.edu<\/a><\/li>\n <li>Hamann, A.K., et al. “Comparative Effects of Allulose and Sugar Alternatives on Glycemic and Cardiometabolic Parameters: A Systematic Review.” <em>Current Developments in Nutrition<\/em>, vol. 9, suppl. 2, 2025. <a href=\"https:\/\/cdn.nutrition.org\/article\/S2475-2991(25)02060-8\/fulltext\" target=\"_blank\" rel=\"noopener\">cdn.nutrition.org<\/a><\/li>\n <li>CSPI \/ Nutrition Action. “Which Low-Calorie Sweeteners Are Safe, and Which Aren’t?” 2023. <a href=\"https:\/\/www.cspi.org\/article\/which-low-calorie-sweeteners-are-safe-and-which-arent\" target=\"_blank\" rel=\"noopener\">cspi.org<\/a><\/li>\n <li>Cleveland Clinic. “Allulose: What It Is and Side Effects.” 2024. <a href=\"https:\/\/health.clevelandclinic.org\/what-is-allulose\" target=\"_blank\" rel=\"noopener\">health.clevelandclinic.org<\/a><\/li>\n <li>Whole Foods Market. “Food Ingredient Quality Standards.” <a href=\"https:\/\/www.wholefoodsmarket.com\/quality-standards\/food-ingredient-standards\" target=\"_blank\" rel=\"noopener\">wholefoodsmarket.com<\/a><\/li>\n <li>Bevi. “Allulose 101: A Curious Alternative Sweetener.” 2025. <a href=\"https:\/\/bevi.co\/blog\/allulose-sugar\/\" target=\"_blank\" rel=\"noopener\">bevi.co<\/a><\/li>\n \n<\/ol>\n<\/div>\n\n<\/article>\n<\/div>\n\n<\/body><\/html>\n","protected":false},"featured_media":7941,"template":"","meta":{"_acf_changed":false,"_seopress_robots_primary_cat":"","_seopress_titles_title":"Allulose vs Sucralose: Key Differences for Food Formulation","_seopress_titles_desc":"Compare allulose and sucralose by sweetness, calories, dosage, browning, labeling, and practical food formulation use.","_seopress_robots_index":""},"categories":[],"class_list":["post-7953","blogs","type-blogs","status-publish","has-post-thumbnail","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.saigaoingredients.com\/ar\/wp-json\/wp\/v2\/blogs\/7953","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.saigaoingredients.com\/ar\/wp-json\/wp\/v2\/blogs"}],"about":[{"href":"https:\/\/www.saigaoingredients.com\/ar\/wp-json\/wp\/v2\/types\/blogs"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.saigaoingredients.com\/ar\/wp-json\/wp\/v2\/media\/7941"}],"wp:attachment":[{"href":"https:\/\/www.saigaoingredients.com\/ar\/wp-json\/wp\/v2\/media?parent=7953"}],"wp:term":[{"taxonomy":"categories","embeddable":true,"href":"https:\/\/www.saigaoingredients.com\/ar\/wp-json\/wp\/v2\/categories?post=7953"}],"curies":[{"name":"\u062f\u0628\u0644\u064a\u0648 \u0628\u064a","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}

{"id":7953,"date":"2026-09-18T03:14:29","date_gmt":"2026-09-18T03:14:29","guid":{"rendered":"https:\/\/www.saigaoingredients.com\/?post_type=blogs&p=7953"},"modified":"2026-10-08T08:47:20","modified_gmt":"2026-10-08T08:47:20","slug":"allulose-vs-sucralose","status":"publish","type":"blogs","link":"https:\/\/www.saigaoingredients.com\/ar\/blogs\/allulose-vs-sucralose\/","title":{"rendered":"\u0627\u0644\u0623\u0644\u0648\u0644\u0648\u0632 \u0645\u0642\u0627\u0628\u0644 \u0627\u0644\u0633\u0643\u0631\u0627\u0644\u0648\u0632: \u0627\u0644\u0641\u0631\u0642 \u0641\u064a \u0627\u0644\u062c\u0631\u0639\u0629 \u0627\u0644\u0630\u064a \u064a\u0628\u0644\u063a 800 \u0636\u0639\u0641\u060c \u0648\u0647\u0648 \u0645\u0627 \u064a\u0641\u0633\u0631 \u0643\u0644 \u0634\u064a\u0621"},"content":{"rendered":"\n\n\n\n\nAllulose vs Sucralose: The 800-Fold Dose Difference That Explains Everything<\/title>\n<\/head>\n<body>\n\n<div class=\"bd-post\">\n<style>\n@import url('https:\/\/fonts.googleapis.com\/css2?family=Inter:wght@500;600;700&display=swap');\n\n.bd-post {\n --prose-width: 744px;\n --gap-attach: 16px;\n --gap-normal: 32px;\n --gap-section: 48px;\n --pad-compact: 16px;\n --pad-standard: 24px;\n --body-bg: #FFFFFF;\n --text-primary: #000000;\n --text-secondary: #666666;\n --text-accent: #3D7A28;\n --card-fill: #F6FCEA;\n --card-border: #5C9647;\n --inverse-bg: #232E34;\n --inverse-text-primary: #FFFFFF;\n --inverse-text-secondary: #A0B0A0;\n --inverse-text-accent: #9FE125;\n --accent: #9FE125;\n --accent-hover: #65A54E;\n --btn-white: #FFFFFF;\n --btn-ink: #232E34;\n font-family: \"Inter\", sans-serif;\n font-size: 16px;\n font-weight: 500;\n line-height: 1.5;\n color: var(--text-primary);\n background: var(--body-bg);\n padding: 40px;\n max-width: 100%;\n box-sizing: border-box;\n}\n.bd-post a { overflow-wrap: anywhere; word-break: break-word; }\n.bd-post p a, .bd-post li a, .bd-post blockquote a, .bd-post td a {\n color: var(--text-accent);\n text-decoration: underline;\n text-decoration-color: var(--card-border);\n text-underline-offset: 2px;\n}\n.bd-post p, .bd-post li { overflow-wrap: break-word; }\n.bd-post .bd-post-article { max-width: var(--prose-width); margin: 0 auto; }\n\n.bd-post p { margin: 0 0 1em; }\n.bd-post h1 { font-family: \"Inter\", sans-serif; font-weight: 600; font-size: 50px; line-height: 1.2; color: var(--text-primary); margin: 0 0 16px; }\n.bd-post h2 { font-family: \"Inter\", sans-serif; font-weight: 600; font-size: 45px; line-height: 1.2; color: var(--text-primary); margin: 48px 0 16px; transform-origin: left center; }\n.bd-post h3 { font-family: \"Inter\", sans-serif; font-weight: 600; font-size: 28px; line-height: 1.2; color: var(--text-primary); margin: 32px 0 12px; }\n.bd-post h4 { font-weight: 600; line-height: 1.2; margin: 24px 0 8px; }\n.bd-post ul, .bd-post ol { margin: 0 0 1em; padding-left: 1.5em; }\n.bd-post li { margin-bottom: 0.5em; }\n.bd-post strong { font-weight: 700; }\n.bd-post em { font-style: italic; }\n\n.bd-post [class*=\"bp-\"] { box-sizing: border-box; }\n.bd-post .bd-post-article > .bp-answer-callout { margin: var(--gap-normal) 0; }\n.bd-post .bd-post-article > .rich-block { margin: var(--gap-normal) 0; }\n.bd-post .bd-post-article > .bp-hook-stat { margin: var(--gap-attach) 0 var(--gap-normal); }\n.bd-post .bd-post-article > .bp-gras-callout { margin: var(--gap-attach) 0 var(--gap-normal); }\n.bd-post .bd-post-article > .bp-cta-mid { margin: var(--gap-section) 0; }\n.bd-post .bd-post-article > .bp-cta-end { margin: var(--gap-section) 0; }\n.bd-post .bd-post-article > .bp-answer-callout:first-child { margin-top: 0; }\n\n\/* BP-0 answer callout (low: tint + border + left bar) *\/\n.bd-post .bp-answer-callout {\n background: var(--card-fill);\n border: 1px solid var(--card-border);\n border-left: 4px solid var(--card-border);\n border-radius: 20px 0 20px 0;\n padding: var(--pad-compact);\n}\n.bd-post .bp-answer-label {\n display: flex; align-items: center; gap: 8px;\n font-size: 18px; font-weight: 600; color: var(--text-accent);\n margin: 0 0 8px;\n}\n.bd-post .bp-answer-icon { display: inline-flex; vertical-align: -0.2em; color: var(--text-accent); }\n.bd-post .bp-answer-text { margin: 0; font-size: 16px; color: var(--text-primary); }\n\n\/* BP-1 hook stat (high: accent solid fill) *\/\n.bd-post .bp-hook-stat {\n background: var(--accent);\n color: var(--btn-ink);\n border-radius: 20px 0 20px 0;\n box-shadow: 5px 5px 0 var(--inverse-bg);\n padding: var(--pad-standard);\n}\n.bd-post .bp-hook-label {\n display: flex; align-items: center; gap: 8px;\n font-size: 16px; font-weight: 600; margin: 0 0 8px;\n}\n.bd-post .bp-hook-icon { display: inline-flex; vertical-align: -0.2em; }\n.bd-post .bp-hook-num { font-size: 64px; font-weight: 700; line-height: 1.1; margin: 0 0 8px; }\n.bd-post .bp-hook-line { font-size: 18px; font-weight: 600; margin: 0 0 8px; }\n.bd-post .bp-hook-micro { font-size: 14px; margin: 0; }\n\n\/* BP-cta-mid (panel-button on card-fill) *\/\n.bd-post .bp-cta-mid {\n background: var(--card-fill);\n border: 1px solid var(--card-border);\n border-radius: 20px 0 20px 0;\n padding: var(--pad-standard);\n display: flex; align-items: center; justify-content: space-between; gap: 24px;\n}\n.bd-post .bp-cta-mid-text { margin: 0; font-size: 17px; color: var(--text-primary); }\n.bd-post .bp-cta-mid-btn {\n display: inline-flex; align-items: center; gap: 8px;\n background: var(--btn-ink); color: var(--btn-white);\n border-radius: 100px; padding: 15px 28px;\n font-size: 16px; font-weight: 600; line-height: 1.2;\n text-decoration: none; white-space: nowrap;\n transition: transform .2s ease-out, box-shadow .2s ease-out;\n}\n\n\/* BP-3 GRAS callout (low) *\/\n.bd-post .bp-gras-callout {\n background: var(--card-fill);\n border: 1px solid var(--card-border);\n border-left: 4px solid var(--card-border);\n border-radius: 20px 0 20px 0;\n padding: var(--pad-compact);\n}\n.bd-post .bp-gras-label {\n display: flex; align-items: center; gap: 8px;\n font-size: 18px; font-weight: 600; color: var(--text-accent);\n margin: 0 0 8px;\n}\n.bd-post .bp-gras-icon { display: inline-flex; vertical-align: -0.2em; color: var(--text-accent); }\n.bd-post .bp-gras-text { margin: 0; font-size: 16px; color: var(--text-primary); }\n\n\/* BP-cta-end (panel-button on inverse) *\/\n.bd-post .bp-cta-end {\n background: var(--inverse-bg);\n border-radius: 20px 0 20px 0;\n padding: 32px 40px;\n display: flex;\n flex-direction: column;\n align-items: center;\n text-align: center;\n}\n.bd-post .bp-cta-end-head { display: flex; align-items: center; justify-content: center; gap: 12px; }\n.bd-post .bp-cta-end-icon { display: flex; flex: 0 0 auto; margin: 0; color: var(--inverse-text-accent); }\n.bd-post .bp-cta-end-title { font-size: 24px; font-weight: 600; color: var(--inverse-text-primary); margin: 0; }\n.bd-post .bp-cta-end-sub { max-width: 680px; font-size: 16px; line-height: 1.45; color: var(--inverse-text-secondary); margin: 12px 0 20px; }\n.bd-post .bp-cta-end-btn {\n display: inline-flex; align-items: center; gap: 8px;\n background: var(--accent); color: var(--btn-ink);\n border-radius: 100px; padding: 15px 28px;\n font-size: 16px; font-weight: 600; line-height: 1.2;\n text-decoration: none; white-space: nowrap;\n transition: transform .2s ease-out, box-shadow .2s ease-out;\n}\n\n\/* References *\/\n.bd-post .bd-refs { margin: var(--gap-section) 0 0; border-top: 1px solid var(--card-border); }\n.bd-post .bd-refs h2 { font-size: 28px; margin: 48px 0 16px; }\n.bd-post .bd-refs ol { margin: 0; padding-left: 1.5em; }\n.bd-post .bd-refs li { font-size: 14px; line-height: 1.5; color: var(--text-secondary); overflow-wrap: anywhere; word-break: break-word; }\n\n\/* Rich elements *\/\n.bd-post .rich-block {\n background: var(--card-fill);\n border: 1px solid var(--card-border);\n border-radius: 20px 0 20px 0;\n padding: var(--pad-standard);\n}\n.bd-post .rich-title { font-size: 20px; font-weight: 600; color: var(--text-primary); margin: 0 0 12px; }\n.bd-post .rich-title-icon { display: inline-flex; vertical-align: -0.2em; margin-right: 8px; color: var(--text-accent); }\n.bd-post .rich-source { font-size: 13px; color: var(--text-secondary); margin: 12px 0 0; }\n.bd-post .table-wrapper { overflow-x: auto; }\n.bd-post .rich-table table { width: 100%; border-collapse: collapse; font-size: 14px; }\n.bd-post .rich-table th {\n background: var(--card-fill); text-align: left;\n font-weight: 600; color: var(--text-primary);\n border-bottom: 2px solid var(--card-border);\n padding: 10px 12px;\n}\n.bd-post .rich-table td {\n color: var(--text-primary);\n border-bottom: 1px solid var(--card-border);\n padding: 10px 12px; vertical-align: top;\n}\n.bd-post .rich-table tr:last-child td { border-bottom: none; }\n.bd-post .rich-stats-grid { display: grid; grid-template-columns: repeat(2, 1fr); gap: 16px; }\n.bd-post .rich-stat-num { font-size: 28px; font-weight: 700; color: var(--text-accent); margin: 0 0 4px; }\n.bd-post .rich-stat-label { font-size: 14px; color: var(--text-secondary); margin: 0; }\n.bd-post .rich-checklist { display: flex; flex-direction: column; gap: 12px; }\n.bd-post .rich-check-item { display: flex; align-items: flex-start; gap: 8px; margin: 0; }\n.bd-post .rich-check-item svg { flex: 0 0 auto; color: var(--text-accent); margin-top: 3px; }\n.bd-post .rich-check-item span { font-size: 15px; color: var(--text-primary); }\n\n\/* Sanctioned motion *\/\n@media (prefers-reduced-motion: no-preference) {\n @supports (animation-timeline: view()) {\n .bd-post .bd-reveal { animation: bd-fade-in linear both; animation-timeline: view(); animation-range: entry 0% entry 35%; }\n @keyframes bd-fade-in { from { opacity: 0; } to { opacity: 1; } }\n }\n .bd-post h2 { transition: color 0.2s ease-out, transform 0.2s ease-out; }\n .bd-post h2:hover { color: var(--text-accent); transform: scale(1.01); }\n .bd-post .bp-hook-stat { transition: transform .2s ease-out, box-shadow .2s ease-out; }\n .bd-post .bp-hook-stat:hover { transform: translateY(-2px); box-shadow: 7px 7px 0 var(--inverse-bg); }\n .bd-post .bp-cta-mid-btn:hover {\n background: var(--accent-hover); color: var(--btn-ink);\n transform: translateY(-2px); box-shadow: 0 6px 18px rgba(0,0,0,0.15);\n }\n .bd-post .bp-cta-end-btn:hover {\n background: var(--btn-white); color: var(--btn-ink);\n transform: translateY(-2px); box-shadow: 0 6px 18px rgba(0,0,0,0.25);\n }\n .bd-post .bd-post-article a { transition: color .2s ease-out, text-decoration-color .2s ease-out; }\n}\n\n@media (max-width: 768px) {\n .bd-post { padding: 16px; }\n .bd-post h1 { font-size: 32px; }\n .bd-post h2 { font-size: 30px; margin-top: 32px; }\n .bd-post h3 { font-size: 20px; margin-top: 24px; }\n .bd-post .bd-refs h2 { font-size: 22px; }\n .bd-post .bp-hook-num { font-size: 48px; }\n .bd-post .bp-hook-line { font-size: 16px; }\n .bd-post .bp-cta-mid { flex-direction: column; align-items: flex-start; }\n .bd-post .bp-cta-mid-btn, .bd-post .bp-cta-end-btn { display: flex; width: 100%; justify-content: center; }\n .bd-post .rich-stats-grid { grid-template-columns: 1fr; }\n .bd-post .bp-cta-end-title { font-size: 20px; }\n .bd-post .bp-cta-end { align-items: center; padding: 24px; text-align: center; }\n .bd-post .bp-cta-end-head { gap: 10px; align-items: flex-start; }\n .bd-post .bp-answer-label, .bd-post .bp-gras-label { font-size: 16px; }\n}\n\/* Force the bottom border of every rich table *\/\n.bd-post .rich-table {\n border-bottom: 1px solid var(--card-border) !important;\n}\n\n.bd-post .rich-table tbody tr:last-child > th,\n.bd-post .rich-table tbody tr:last-child > td,\n.bd-post .rich-table > tr:last-child > th,\n.bd-post .rich-table > tr:last-child > td {\n border-bottom: 1px solid var(--card-border) !important;\n}\n<\/style>\n<article class=\"bd-post-article\">\n\n\n<div class=\"bp-answer-callout bd-reveal\">\n <p class=\"bp-answer-label\"><span class=\"bp-answer-icon\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"18\" height=\"18\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><circle cx=\"12\" cy=\"12\" r=\"10\"\/><path d=\"M12 16v-4\"\/><path d=\"M12 8h.01\"\/><\/svg><\/span>The short answer<\/p>\n <p class=\"bp-answer-text\">No. They are not the same thing, and not even the same kind of sweetener.<\/p>\n<\/div>\n\n<h2>Two Sweeteners, Two Categories: What Allulose and Sucralose Actually Are<\/h2>\n<p>Allulose is a rare sugar: a C-3 epimer of fructose that occurs naturally in trace amounts in figs, raisins, wheat, and maple syrup, and is produced commercially from starch-derived fructose (<a href=\"https:\/\/health.clevelandclinic.org\/what-is-allulose\">Cleveland Clinic<\/a>, 2024). Sucralose is a chlorinated derivative of table sugar, roughly 600 times sweeter, regulated in the United States as a food additive (<a href=\"https:\/\/www.fda.gov\/food\/food-additives-petitions\/aspartame-and-other-sweeteners-food\">FDA<\/a>, 2025).<\/p>\n<p>The difference that organizes everything else is the category each one works in. Allulose is a <strong>bulk sweetener<\/strong>: you dose it by weight, close to sugar, and it brings physical mass into a recipe. Sucralose is a <strong>high-intensity sweetener<\/strong>: you dose it in parts per million, and it brings sweetness and nothing else. In typical use, allulose enters at 125 to 140 percent of sugar’s weight to match its sweetness. Sucralose enters at around 0.16 percent (<a href=\"https:\/\/bevi.co\/blog\/allulose-sugar\/\">Bevi<\/a>, 2025). That works out to a dose gap of roughly 800 times between the two.<\/p>\n<p>Part of the confusion online comes from a naming fight that regulators never joined. Some medical content calls allulose an “artificial sweetener” while describing it, in the same article, as a naturally occurring sugar; brand blogs insist allulose is natural and sucralose is artificial. The regulatory categories are different from both. FDA recognizes allulose as a low-calorie sweetener with GRAS status and treats sucralose as a food additive with an acceptable daily intake (<a href=\"https:\/\/www.fda.gov\/food\/food-additives-petitions\/aspartame-and-other-sweeteners-food\">FDA<\/a>, 2025). “Natural versus artificial” is a marketing binary, not a regulatory one, and it explains why the search results disagree with each other more than with the underlying facts.<\/p>\n<p>One more source of confusion is worth clearing up immediately, because it generates a huge share of the “are they the same” searches: the best-known sucralose tabletop brand also sells a line of allulose products under the same brand name. The brand’s own FAQ states that its yellow packets are sucralose and that its allulose products contain no sucralose (Splenda FAQ, 2026). Same brand, two unrelated sweeteners. If you have seen both names near each other on a shelf, that is why.<\/p>\n\n<div class=\"rich-block rich-table bd-reveal\">\n <p class=\"rich-title\">Allulose and Sucralose: The Foundation Comparison<\/p>\n <div class=\"table-wrapper\">\n <table>\n <thead><tr><th>Dimension<\/th><th>Allulose<\/th><th>Sucralose<\/th><\/tr><\/thead>\n <tbody>\n <tr><td>Origin & chemistry<\/td><td>Rare sugar, C-3 epimer of fructose, produced from starch-derived fructose<\/td><td>Chlorinated derivative of sucrose (E955)<\/td><\/tr>\n <tr><td>Sweetness vs sugar<\/td><td>About 70%<\/td><td>About 600x<\/td><\/tr>\n <tr><td>Typical use level<\/td><td>125–140% of sugar’s weight<\/td><td>~0.16% of sugar’s weight<\/td><\/tr>\n <tr><td>Calories<\/td><td>0.4 kcal\/g<\/td><td>0 per molecule (packet carriers add ~3 kcal\/serving)<\/td><\/tr>\n <tr><td>US status<\/td><td>Low-calorie sweetener, GRAS<\/td><td>Food additive, ADI 5 mg\/kg bw\/day<\/td><\/tr>\n <tr><td>What it brings to a formula<\/td><td>Sweetness + bulk + browning<\/td><td>Sweetness only<\/td><\/tr>\n <\/tbody>\n <\/table>\n <\/div>\n <p class=\"rich-source\">DataSource: FDA (2025, 2020); Bevi (2025); UC Davis; published manufacturer spec sheets<\/p>\n<\/div>\n\n<p>With the categories separated, the practical question changes shape. It is no longer “which one is better,” but “what does an equal-sweetness swap actually deliver,” which is a very different calculation than most articles give you.<\/p>\n\n<h2>What an Equal-Sweetness Swap Actually Delivers: Dose, Calories, and Tolerance<\/h2>\n<h3>The 800-Fold Usage Gap<\/h3>\n<p>To replace the sweetness of one gram of sugar, you need about 1.3 grams of allulose. To replace it with sucralose, you need about 0.0016 grams (<a href=\"https:\/\/bevi.co\/blog\/allulose-sugar\/\">Bevi<\/a>, 2025).<\/p>\n\n\n<div class=\"bp-hook-stat bd-reveal\">\n <p class=\"bp-hook-label\"><span class=\"bp-hook-icon\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"20\" height=\"20\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><polyline points=\"22 7 13.5 15.5 8.5 10.5 2 17\"\/><polyline points=\"16 7 22 7 22 13\"\/><\/svg><\/span>The dose gap<\/p>\n <p class=\"bp-hook-num\">800×<\/p>\n <p class=\"bp-hook-line\">Swap for sweetness and you shift the dose by roughly 800-fold. Every downstream difference in this article follows from that one number.<\/p>\n <p class=\"bp-hook-micro\">Equal sweetness: 1.3× the weight in allulose vs 0.16% in sucralose<\/p>\n<\/div>\n\n<p>Calorie math, digestive tolerance, baking behavior, even the shape of the safety studies: all of it is the 800-fold gap, wearing different costumes.<\/p>\n<h3>What a Serving Actually Delivers<\/h3>\n<p>Allulose contributes 0.4 kcal\/g. Under FDA’s final labeling guidance, manufacturers count it in calories at 0.4 kcal\/g but may exclude it from the Total Sugars and Added Sugars declarations (<a href=\"https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/guidance-industry-declaration-allulose-and-calories-allulose-nutrition-and-supplement-facts-labels\">FDA<\/a>, 2020). Because you use it at sugar-like weights, the calories are small but real: a cup of one popular keto cereal carries about 10 g of allulose (<a href=\"https:\/\/www.cspi.org\/article\/which-low-calorie-sweeteners-are-safe-and-which-arent\">CSPI<\/a>, 2023).<\/p>\n<p>Sucralose is the opposite case. The molecule delivers zero calories, but granulated packet products get their bulk from dextrose and maltodextrin carriers, and one packet delivers about 3 kcal while sweetening like two teaspoons of sugar (<a href=\"https:\/\/nutrition.ucdavis.edu\/outreach\/nutr-health-info-sheets\/pro-nonnutritive-sweeteners\">UC Davis<\/a>; <a href=\"https:\/\/www.fda.gov\/media\/168517\/download?attachment\">FDA<\/a>). If you count net carbs, the “zero calorie” packet is not zero-carb, which is exactly why low-carb bakers migrate to liquid sucralose drops, which skip the carrier entirely. Neither sweetener’s label story survives at the serving level without reading the other ingredients.<\/p>\n<h3>Tolerance Runs on Two Different Systems<\/h3>\n<p>Allulose tolerance is <strong>threshold-based<\/strong>: fine at moderate doses, dose-dependent at high ones. In a 29-person escalating-dose study, participants had no symptoms at a single 27 g dose, while roughly one third reported diarrhea, bloating, or abdominal pain at about 35 g (figures scaled to a 150-pound adult) (<a href=\"https:\/\/www.cspi.org\/article\/which-low-calorie-sweeteners-are-safe-and-which-arent\">CSPI<\/a>, 2023). China’s approval sets a recommended intake of no more than 20 g\/day and excludes infants, pregnant and breastfeeding women (<a href=\"https:\/\/zwfw.nhc.gov.cn\/kzx\/tzgg\/sptjjxpzsp_224\/202507\/t20250702_3106.html\">NHC Announcement No. 4, 2025<\/a>, 2025). Individual sensitivity varies; some people report digestive effects well below the trial thresholds.<\/p>\n<p>Sucralose tolerance is <strong>ADI-based<\/strong>: 5 mg per kilogram of body weight per day (<a href=\"https:\/\/www.fda.gov\/food\/food-additives-petitions\/aspartame-and-other-sweeteners-food\">FDA<\/a>, 2025). For a 60 kg adult, that is about 300 mg\/day, orders of magnitude above typical dietary exposure from finished products. The two systems are not comparable: a dose-based threshold and a body-weight ADI answer different questions, and treating them as equivalent is a category error.<\/p>\n\n<div class=\"rich-block rich-stats bd-reveal\">\n <p class=\"rich-title\"><span class=\"rich-title-icon\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"20\" height=\"20\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><polyline points=\"22 7 13.5 15.5 8.5 10.5 2 17\"\/><polyline points=\"16 7 22 7 22 13\"\/><\/svg><\/span>The Threshold Numbers<\/p>\n <div class=\"rich-stats-grid\">\n <div><p class=\"rich-stat-num\">27 g<\/p><p class=\"rich-stat-label\">Allulose single dose — no symptoms (29-person trial, 150-lb basis)<\/p><\/div>\n <div><p class=\"rich-stat-num\">~35 g<\/p><p class=\"rich-stat-label\">About 1\/3 of adults report GI effects at this single dose<\/p><\/div>\n <div><p class=\"rich-stat-num\">≤ 20 g\/day<\/p><p class=\"rich-stat-label\">Allulose recommended intake (China NHC approval)<\/p><\/div>\n <div><p class=\"rich-stat-num\">5 mg\/kg<\/p><p class=\"rich-stat-label\">Sucralose ADI, per kg body weight per day (≈300 mg for a 60 kg adult)<\/p><\/div>\n <\/div>\n <p class=\"rich-source\">DataSource: CSPI (2023); NHC Announcement No. 4 (2025); FDA (2025)<\/p>\n<\/div>\n\n<h3>The Kidney Question, Answered Precisely<\/h3>\n<p>A recurring search asks whether allulose is hard on the kidneys. The precise answer: allulose is absorbed in the small intestine, not metabolized, and excreted by the kidneys mostly intact (<a href=\"https:\/\/health.clevelandclinic.org\/what-is-allulose\">Cleveland Clinic<\/a>, 2024). Renal excretion is a <em>route<\/em>, not an injury. No published evidence shows kidney damage at recommended intakes, and the honest position is that long-term high-dose data are still accumulating. “It passes through the kidneys” and “it burdens the kidneys” are different claims; only the first is supported.<\/p>\n<p>That is what crosses the consumer’s plate. What happens inside a formulation follows the same 800-fold logic, and it is where the two sweeteners stop competing altogether.<\/p>\n\n\n<div class=\"bp-cta-mid bd-reveal\">\n <p class=\"bp-cta-mid-text\">Need these thresholds as a working document? We publish the complete allulose crystal and syrup spec tables.<\/p>\n <a class=\"bp-cta-mid-btn\" href=\"https:\/\/www.saigaoingredients.com\/contact\/\">Request the spec sheet<svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"18\" height=\"18\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><path d=\"M5 12h14\"\/><path d=\"m12 5 7 7-7 7\"\/><\/svg><\/a>\n<\/div>\n\n<h2>Inside the Formula: Why Real Products Use Both Together<\/h2>\n<p>A bulk sweetener does structural work. Allulose, as a reducing sugar, participates in the Maillard reaction: it browns like sucrose, often faster (<a href=\"https:\/\/bevi.co\/blog\/allulose-sugar\/\">Bevi<\/a>, 2025). It retains moisture in baked goods, depresses freezing point for scoopable ice cream, and does not crystallize into grit the way erythritol can. A high-intensity sweetener does none of this. Sucralose provides sweetness at negligible mass; it cannot build crust color, body, or bulk, because it contributes essentially no mass at all.<\/p>\n<p>This is why real products so often contain both. A reader on a nutrition forum put it plainly while reviewing a keto product’s label: “Allulose is only about 70 percent as sweet as table sugar. So the sucralose makes up for that deficiency.” A 70-percent-sweet bulk sugar plus a 600-times-sweet intensity top-up cover each other’s gaps: the bulk side brings mass, browning, and sugar-like taste; the intensity side closes the sweetness deficit without adding weight or cost. The market has already voted on this structure: the biggest sucralose tabletop brand now sells an allulose-based baking line under its own roof (Splenda FAQ, 2026). “Allulose vs sucralose” is, in formulation terms, mostly a false binary. They are colleagues, not candidates.<\/p>\n\n<div class=\"rich-block rich-table bd-reveal\">\n <p class=\"rich-title\">Who Brings What into the Formula<\/p>\n <div class=\"table-wrapper\">\n <table>\n <thead><tr><th>Function<\/th><th>Allulose (bulk)<\/th><th>Sucralose (high-intensity)<\/th><\/tr><\/thead>\n <tbody>\n <tr><td>Sweetness<\/td><td>70% of sugar; sugar-like, no aftertaste<\/td><td>600x; tops up any gap at ppm dose<\/td><\/tr>\n <tr><td>Bulk & structure<\/td><td>Full mass contribution; body and texture<\/td><td>None; negligible mass<\/td><\/tr>\n <tr><td>Browning & crust<\/td><td>Reducing sugar; browns via Maillard, often faster than sugar<\/td><td>No browning contribution<\/td><\/tr>\n <tr><td>Moisture<\/td><td>Retains moisture in soft textures<\/td><td>No moisture function<\/td><\/tr>\n <tr><td>Frozen texture<\/td><td>Depresses freezing point; smooth, scoopable<\/td><td>No freezing-point function<\/td><\/tr>\n <tr><td>Cost-in-use<\/td><td>Priced per kg, used at 1.3x sugar weight<\/td><td>Tiny dose; lowest cost per sweetness unit<\/td><\/tr>\n <\/tbody>\n <\/table>\n <\/div>\n <p class=\"rich-source\">DataSource: Bevi (2025); published allulose crystal & syrup spec sheets; CSPI (2023)<\/p>\n<\/div>\n\n<p>The swap rules follow directly. Replacing sugar with allulose: use about 1.3 times the weight, expect faster browning, and adjust by lowering oven temperature roughly 25°F or shortening bake time while watching crust color. Replacing sugar with sucralose by weight is where recipes break predictably: crust color, caramel notes, cookie spread, and bulk all come from sugar’s mass and reducing activity, none of which a ppm-dose sweetener supplies. The boundary is easy to state as a check: if the recipe’s color and structure come from sugar, only a bulk sweetener can carry them; if only sweetness matters (beverages, sauces, tabletop use), the high-intensity option wins on cost-in-use. And one moisture caveat cuts the other way: allulose holds water, so shelf-life and water activity calculations should be redone when it enters a formula at sugar-like levels.<\/p>\n<p>Formulation behavior, however, is only half of the professional’s checklist. The other half is evidence and market access, where the two sweeteners are treated very differently by regulators and retailers alike.<\/p>\n\n<h2>What the Evidence Says, and Where Each Sweetener Can Be Sold<\/h2>\n<h3>Why the Safety Verdicts Disagree<\/h3>\n<p>The public record looks contradictory because the two sweeteners generate two different shapes of evidence. A bulk sweetener eaten at gram-level dietary exposure gets tested with dose-response and tolerance trials. A high-intensity sweetener consumed at milligram levels gets tested with ADI toxicology and mechanism studies. Comparing them on one scale produces exactly the confusion you see in the search results.<\/p>\n<p>Take the two most quoted verdicts. A consumer-advocacy review concludes: “Allulose is safe, but it may cause GI woes in sensitive people,” while flagging that no studies have tested allulose in children or people with GI conditions (<a href=\"https:\/\/www.cspi.org\/article\/which-low-calorie-sweeteners-are-safe-and-which-arent\">CSPI<\/a>, 2023). A cardiovascular researcher known for erythritol and xylitol clotting studies recommends avoiding allulose until more data exist (<a href=\"https:\/\/health.clevelandclinic.org\/what-is-allulose\">Cleveland Clinic<\/a>, 2024). He states plainly that allulose-specific studies are not available, and that his caution is extrapolated from other sweeteners. Those are not contradictory facts; they are different evidence standards applied to the same thin long-term record.<\/p>\n<p>Sucralose’s evidence file has its own texture. An animal study reported leukemia in mice exposed from fetus to death, summarized by the same consumer review with the caveat that results across studies are mixed (<a href=\"https:\/\/www.cspi.org\/article\/which-low-calorie-sweeteners-are-safe-and-which-arent\">CSPI<\/a>, 2023). In the best human trial on record, 60 adults consumed the equivalent of about six packets a day for two weeks and showed reduced glucose tolerance; stool transplants from the top responders transmitted the effect to germ-free mice, implicating microbiome changes (<a href=\"https:\/\/www.cspi.org\/article\/which-low-calorie-sweeteners-are-safe-and-which-arent\">CSPI<\/a>, 2023). None of these findings is dispositive on its own. Each answers a different question, and a formulation decision should know which question it is asking.<\/p>\n\n <img decoding=\"async\" src=\"https:\/\/www.saigaoingredients.com\/wp-content\/uploads\/2026\/09\/Allulose-vs-Sucralose.webp\" style=\"width: 512px; height: 384px; max-width: 100%; object-fit: cover; border-radius: 12px; margin: 30px auto; display: block; box-shadow: 10px 10px 60px 0px rgba(210, 221, 224, 0.35); transition: all 0.3s ease; cursor: pointer;\" onmouseover=\"this.style.transform='translateY(-5px) scale(1.03)'; this.style.boxShadow='15px 25px 80px 0px rgba(210, 221, 224, 0.45)'\" onmouseout=\"this.style.transform='translateY(0) scale(1)'; this.style.boxShadow='10px 10px 60px 0px rgba(210, 221, 224, 0.35)'\"> \n\n<h3>The Head-to-Head Data That Exists So Far<\/h3>\n<p>Direct comparisons are rare but they are starting to appear. A 2025 systematic review in <em>Current Developments in Nutrition<\/em> compared allulose against other sweeteners across glycemic and cardiometabolic outcomes: allulose reduced BMI relative to sucralose over 12 weeks, and improved post-prandial glucose relative to aspartame (<a href=\"https:\/\/cdn.nutrition.org\/article\/S2475-2991(25)02060-8\/fulltext\">Hamann et al.<\/a>, 2025). The evidence base is young and the review is comparative, not mechanistic, but the direction matters: the first head-to-head data do not flatter sucralose. Meanwhile, per the consumer review’s summary, sucralose is one of only two sweeteners with consistent microbiome-altering signals in sensitive people.<\/p>\n<h3>Where Each Sweetener Can Be Sold<\/h3>\n<p>Regulatory status is where formulation decisions meet market decisions. The map, as of this writing:<\/p>\n\n<div class=\"rich-block rich-table bd-reveal\">\n <p class=\"rich-title\">Market Access and Labeling: Allulose vs Sucralose<\/p>\n <div class=\"table-wrapper\">\n <table>\n <thead><tr><th>Market<\/th><th>Allulose<\/th><th>Sucralose<\/th><\/tr><\/thead>\n <tbody>\n <tr><td>United States<\/td><td>GRAS; excluded from Total & Added Sugars; calories at 0.4 kcal\/g<\/td><td>Approved food additive; ADI 5 mg\/kg bw\/day<\/td><\/tr>\n <tr><td>European Union<\/td><td>Not approved; novel food applications pending (often mislabeled “banned”)<\/td><td>Approved (E955)<\/td><\/tr>\n <tr><td>Canada<\/td><td>Not approved as a food sweetener<\/td><td>Approved<\/td><\/tr>\n <tr><td>China<\/td><td>Approved July 2025 as novel food ingredient: ≥98 g\/100 g purity, recommended ≤20 g\/day, not for infants\/pregnant\/breastfeeding<\/td><td>Approved food additive<\/td><\/tr>\n <tr><td>Japan, Korea, Mexico, Singapore<\/td><td>Approved early<\/td><td>Approved<\/td><\/tr>\n <\/tbody>\n <\/table>\n <\/div>\n <p class=\"rich-source\">DataSource: FDA (2020, 2025); NHC Announcement No. 4 (2025); Cleveland Clinic (2024); EU\/CA status per cited reviews<\/p>\n<\/div>\n\n<p>Two details on that map deserve attention. First, the energy factor assigned to allulose is not globally uniform: China’s announcement pegs it at ≈1.67 kJ\/g (about 0.4 kcal\/g), and other regulators set their own values, so label math does not transfer across borders unchanged.<\/p>\n<p>Second, “approved” and “available everywhere” are different questions, because retailers run their own standards on top of the regulators’. Whole Foods Market’s ingredient standards ban more than 300 ingredients and explicitly name sucralose, alongside aspartame and saccharin (<a href=\"https:\/\/www.wholefoodsmarket.com\/quality-standards\/food-ingredient-standards\">Whole Foods Market<\/a>, 2026); industry reporting indicates allulose is excluded there as well, though the official page does not name it, so treat that one as reported rather than official (Icon Foods, 2025). The actionable version of this: before locking a sweetener system for a product, verify regulatory status for each target market <em>and<\/em> the ingredient standards of your target retail channels.<\/p>\n\n\n<div class=\"bp-gras-callout bd-reveal\">\n <p class=\"bp-gras-label\"><span class=\"bp-gras-icon\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"18\" height=\"18\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><path d=\"m21.73 18-8-14a2 2 0 0 0-3.48 0l-8 14A2 2 0 0 0 4 20h16a2 2 0 0 0 1.73-2Z\"\/><path d=\"M12 9v4\"\/><path d=\"M12 17h.01\"\/><\/svg><\/span>Channel check<\/p>\n <p class=\"bp-gras-text\">GRAS status is federal approval, not guaranteed shelf access. Before locking a sweetener system, verify each target market’s regulatory status and every target retailer’s ingredient standards: both can exclude an approved sweetener.<\/p>\n<\/div>\n\n<h2>Choosing a Sweetener System: What to Ask a Supplier<\/h2>\n<p>Once the categories are clear, the purchase question stops being “which sweetener is better” and becomes “which one carries the bulk, and which one closes the sweetness gap.” Bakery and frozen applications tend to go allulose-forward, because browning, moisture, and freezing-point depression are the product. Beverage and sauce applications tend to go intensity-forward, because only sweetness matters and cost-per-sweetness dominates. Tabletop blends and keto confectionery increasingly do both at once. The market signal is consistent: commercial beverage operators are publicly evaluating allulose for their lines, and the leading sucralose brand already sells allulose-based baking products (<a href=\"https:\/\/bevi.co\/blog\/allulose-sugar\/\">Bevi<\/a>, 2025; Splenda FAQ, 2026).<\/p>\n<p>Cost comparisons only work in one accounting mode. Per-kilogram price is meaningless across categories when one ingredient goes in at 1.3 times sugar weight and the other at 0.16 percent. Per-sweetness-unit price favors sucralose but ignores everything the bulk side contributes. The only number that survives contact with a real recipe is cost-in-use: the system total, including carriers, bulking corrections, and label consequences. Ask every supplier to quote on that basis, or the quotes are not comparable.<\/p>\n<p>The supplier evaluation is then a short, checkable list:<\/p>\n\n<div class=\"rich-block rich-checklist bd-reveal\">\n <p class=\"rich-title\"><span class=\"rich-title-icon\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"20\" height=\"20\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><path d=\"m3 17 2 2 4-4\"\/><path d=\"m3 7 2 2 4-4\"\/><path d=\"M13 6h8\"\/><path d=\"M13 12h8\"\/><path d=\"M13 18h8\"\/><\/svg><\/span>Supplier Evaluation Checklist<\/p>\n <div class=\"rich-checklist\">\n <p class=\"rich-check-item\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"18\" height=\"18\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><circle cx=\"12\" cy=\"12\" r=\"10\"\/><path d=\"m9 12 2 2 4-4\"\/><\/svg><span>Can one source supply both lines (bulk + high-intensity), plus blends?<\/span><\/p>\n <p class=\"rich-check-item\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"18\" height=\"18\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><circle cx=\"12\" cy=\"12\" r=\"10\"\/><path d=\"m9 12 2 2 4-4\"\/><\/svg><span>Are spec tables published for every form offered?<\/span><\/p>\n <p class=\"rich-check-item\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"18\" height=\"18\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><circle cx=\"12\" cy=\"12\" r=\"10\"\/><path d=\"m9 12 2 2 4-4\"\/><\/svg><span>Is blending and spec customization available (viscosity, purity, pH, water activity, particle form, packaging)?<\/span><\/p>\n <p class=\"rich-check-item\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"18\" height=\"18\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><circle cx=\"12\" cy=\"12\" r=\"10\"\/><path d=\"m9 12 2 2 4-4\"\/><\/svg><span>Will they hand over COA and certification documents directly?<\/span><\/p>\n <p class=\"rich-check-item\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"18\" height=\"18\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><circle cx=\"12\" cy=\"12\" r=\"10\"\/><path d=\"m9 12 2 2 4-4\"\/><\/svg><span>What are realistic lead times and MOQ for your volumes?<\/span><\/p>\n <p class=\"rich-check-item\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"18\" height=\"18\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><circle cx=\"12\" cy=\"12\" r=\"10\"\/><path d=\"m9 12 2 2 4-4\"\/><\/svg><span>What is their response time on technical questions?<\/span><\/p>\n <\/div>\n <p class=\"rich-source\">DataSource: Published supplier terms: SAIGAO allulose line and tailored-solutions pages<\/p>\n<\/div>\n\n<p>We build our own published terms around exactly that checklist. Our <a href=\"https:\/\/www.saigaoingredients.com\/sweeteners\/allulose\/\">allulose line<\/a> covers crystal and syrup with full public spec tables: crystal at ≥98.5% D-allulose on a dry basis, syrup at ≥95.0% content with ≥70.0% dry matter, alongside published pH, ash, and microbiological limits. We supply and blend both sweetener lines, and we adjust eight published customization axes: viscosity, purity\/assay, pH, water activity, form and particle size, DE value, fiber content, and packaging (<a href=\"https:\/\/www.saigaoingredients.com\/tailored-solutions\/\">customization<\/a>). Operationally: in-stock powder ships in 7 days, custom orders run 20 to 30 days, bulk orders start at 1 ton, and international inquiries get a 12-hour response.<\/p>\n<p><em>The “which is better” question dissolves once you ask the formulator’s question instead: who carries the bulk, and who closes the sweetness gap. If you want spec sheets and samples to run your own side-by-side trials, <a href=\"https:\/\/www.saigaoingredients.com\/contact\/\">request them here<\/a>.<\/em><\/p>\n\n\n<div class=\"bp-cta-end bd-reveal\">\n <div class=\"bp-cta-end-head\">\n <p class=\"bp-cta-end-icon\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"28\" height=\"28\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><path d=\"M14.536 21.686a.5.5 0 0 0 .937-.024l6.5-19a.496.496 0 0 0-.635-.635l-19 6.5a.5.5 0 0 0-.024.937l7.93 3.18a2 2 0 0 1 1.112 1.11z\"\/><path d=\"m21.854 2.147-10.94 10.939\"\/><\/svg><\/p>\n <p class=\"bp-cta-end-title\">Test Both Sweeteners in Your Own Formula<\/p>\n <\/div>\n <p class=\"bp-cta-end-sub\">Allulose crystal & syrup spec sheets, COA documents and samples. Bulk from 1 ton, custom blends and 8-axis customization.<\/p>\n <a class=\"bp-cta-end-btn\" href=\"https:\/\/www.saigaoingredients.com\/contact\/\">Get Spec Sheets & Samples<svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"18\" height=\"18\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><path d=\"M5 12h14\"\/><path d=\"m12 5 7 7-7 7\"\/><\/svg><\/a>\n<\/div>\n\n<div class=\"bd-refs\">\n<h2>References<\/h2>\n<ol>\n <li>U.S. Food and Drug Administration. “Guidance for Industry: The Declaration of Allulose and Calories From Allulose on Nutrition and Supplement Facts Labels.” 2020. <a href=\"https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/guidance-industry-declaration-allulose-and-calories-allulose-nutrition-and-supplement-facts-labels\" target=\"_blank\" rel=\"noopener\">fda.gov<\/a><\/li>\n <li>U.S. Food and Drug Administration. “Aspartame and Other Sweeteners in Food.” 2025. <a href=\"https:\/\/www.fda.gov\/food\/food-additives-petitions\/aspartame-and-other-sweeteners-food\" target=\"_blank\" rel=\"noopener\">fda.gov<\/a><\/li>\n <li>U.S. Food and Drug Administration. “Safe Levels of Sweeteners (ADI Reference Table).” <a href=\"https:\/\/www.fda.gov\/media\/168517\/download?attachment\" target=\"_blank\" rel=\"noopener\">fda.gov<\/a><\/li>\n <li>National Health Commission of China. “Announcement on 20 ‘Three-New Foods,’ Including D-Allulose (Announcement No. 4 of 2025).” 2025. <a href=\"https:\/\/zwfw.nhc.gov.cn\/kzx\/tzgg\/sptjjxpzsp_224\/202507\/t20250702_3106.html\" target=\"_blank\" rel=\"noopener\">nhc.gov.cn<\/a><\/li>\n <li>UC Davis Clinical Nutrition. “Nutrition & Health Info Sheets: Nonnutritive Sweeteners.” <a href=\"https:\/\/nutrition.ucdavis.edu\/outreach\/nutr-health-info-sheets\/pro-nonnutritive-sweeteners\" target=\"_blank\" rel=\"noopener\">nutrition.ucdavis.edu<\/a><\/li>\n <li>Hamann, A.K., et al. “Comparative Effects of Allulose and Sugar Alternatives on Glycemic and Cardiometabolic Parameters: A Systematic Review.” <em>Current Developments in Nutrition<\/em>, vol. 9, suppl. 2, 2025. <a href=\"https:\/\/cdn.nutrition.org\/article\/S2475-2991(25)02060-8\/fulltext\" target=\"_blank\" rel=\"noopener\">cdn.nutrition.org<\/a><\/li>\n <li>CSPI \/ Nutrition Action. “Which Low-Calorie Sweeteners Are Safe, and Which Aren’t?” 2023. <a href=\"https:\/\/www.cspi.org\/article\/which-low-calorie-sweeteners-are-safe-and-which-arent\" target=\"_blank\" rel=\"noopener\">cspi.org<\/a><\/li>\n <li>Cleveland Clinic. “Allulose: What It Is and Side Effects.” 2024. <a href=\"https:\/\/health.clevelandclinic.org\/what-is-allulose\" target=\"_blank\" rel=\"noopener\">health.clevelandclinic.org<\/a><\/li>\n <li>Whole Foods Market. “Food Ingredient Quality Standards.” <a href=\"https:\/\/www.wholefoodsmarket.com\/quality-standards\/food-ingredient-standards\" target=\"_blank\" rel=\"noopener\">wholefoodsmarket.com<\/a><\/li>\n <li>Bevi. “Allulose 101: A Curious Alternative Sweetener.” 2025. <a href=\"https:\/\/bevi.co\/blog\/allulose-sugar\/\" target=\"_blank\" rel=\"noopener\">bevi.co<\/a><\/li>\n \n<\/ol>\n<\/div>\n\n<\/article>\n<\/div>\n\n<\/body><\/html>\n","protected":false},"featured_media":7941,"template":"","meta":{"_acf_changed":false,"_seopress_robots_primary_cat":"","_seopress_titles_title":"Allulose vs Sucralose: Key Differences for Food Formulation","_seopress_titles_desc":"Compare allulose and sucralose by sweetness, calories, dosage, browning, labeling, and practical food formulation use.","_seopress_robots_index":""},"categories":[],"class_list":["post-7953","blogs","type-blogs","status-publish","has-post-thumbnail","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.saigaoingredients.com\/ar\/wp-json\/wp\/v2\/blogs\/7953","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.saigaoingredients.com\/ar\/wp-json\/wp\/v2\/blogs"}],"about":[{"href":"https:\/\/www.saigaoingredients.com\/ar\/wp-json\/wp\/v2\/types\/blogs"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.saigaoingredients.com\/ar\/wp-json\/wp\/v2\/media\/7941"}],"wp:attachment":[{"href":"https:\/\/www.saigaoingredients.com\/ar\/wp-json\/wp\/v2\/media?parent=7953"}],"wp:term":[{"taxonomy":"categories","embeddable":true,"href":"https:\/\/www.saigaoingredients.com\/ar\/wp-json\/wp\/v2\/categories?post=7953"}],"curies":[{"name":"\u062f\u0628\u0644\u064a\u0648 \u0628\u064a","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}